BIND Therapeutics

BIND Therapeutics is a clinical-stage nanomedicine platform company developing Accurins, a class of highly selective, targeted therapeutics. The job it does: scheduling, records, billing and compliance for clinics and providers.

The natural audience is practices and healthcare organizations. Related areas on their profile: Biotechnology, Clinical Trials, Health Care and Medical. They are a mid-sized team, 51 to 200 people, which usually shapes who they work with.

BIND Therapeutics is based in Cambridge, Massachusetts and founded in 2006. More on bindtherapeutics.com.

Before you commit, look at HIPAA posture, EHR integration, and billing support. A short pilot with your real data tells you more than any demo.

Every review on Revaw shows how it was verified, so if you know BIND Therapeutics well, your review carries weight here.